N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is an inhibitor of human immunodeficiency virus (HIV) replication and HIV-induced syncytium formation in vitro. Although NB-DNJ appears to inhibit HIV entry at the level of post-CD4 binding (P.B. Fischer, M. Collin, G.B. Karlsson, W. J...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Virol
Autores principales:	Fischer, P B, Karlsson, G B, Butters, T D, Dwek, R A, Platt, F M
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1996
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190767/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8794361/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.10.7143-7152.1996
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!